Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

EHA 17: Reduction of chemotherapy and PET-guided radiotherapy in advanced-stage Hodgkin lymphoma: the GHSG HD15 trial

EHA 17: Reduction of chemotherapy and PET-guided radiotherapy in advanced-stage Hodgkin lymphoma: the GHSG HD15...

EHA 17: Malignant cells in patients with chronic lymphocytic leukaemia escape T cell recognition and attack

EHA 17: Malignant cells in patients with chronic lymphocytic leukaemia escape T cell recognition and attack

EHA 17: Evaluation of a single iron dose as ferric carboxymaltose (FCM) for fatigue treatment in iron deficient women

EHA 17: Evaluation of a single iron dose as ferric carboxymaltose (FCM) for fatigue treatment in iron deficient...

$EHA 17: Impressive results in acute lymphocytic leukaemia with the monoclonal antibody blinatumomab in patients with refractory disease$

EHA 17: Impressive results in acute lymphocytic leukaemia with the monoclonal antibody blinatumomab in patients...

EHA 17: International survey of T2* cardiovascular magnetic resonance in thalassemia

EHA 17: International survey of T2* cardiovascular magnetic resonance in thalassemia

Tiny 'speed bump' device could sort cancer cells

Tiny 'speed bump' device could sort cancer cells

Cancer Research Technology and BioInvent enter oncology collaboration

Cancer Research Technology and BioInvent enter oncology collaboration

Hepatitis C 'switch' offers target for new drug research

Hepatitis C 'switch' offers target for new drug research

Carfilzomib demonstrates efficacy as new frontline treatment regimen for multiple myeloma

Carfilzomib demonstrates efficacy as new frontline treatment regimen for multiple myeloma

ASCO 2012: Bendamustine regimen more effective for lymphoma than standard CHOP, with fewer side effects

ASCO 2012: Bendamustine regimen more effective for lymphoma than standard CHOP, with fewer side effects

More from ecancer